Franklin Resources Inc. Boosts Holdings in Smith & Nephew plc (NYSE:SNN)

Franklin Resources Inc. grew its position in Smith & Nephew plc (NYSE:SNN) by 16.8% during the 3rd quarter, Holdings Channel.com reports. The firm owned 114,080 shares of the medical equipment provider’s stock after purchasing an additional 16,397 shares during the period. Franklin Resources Inc.’s holdings in Smith & Nephew were worth $3,265,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Allspring Global Investments Holdings LLC boosted its stake in Smith & Nephew by 1,894.3% in the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider’s stock worth $43,000 after purchasing an additional 1,648 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Smith & Nephew by 92.5% in the second quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider’s stock worth $61,000 after buying an additional 1,179 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Smith & Nephew by 160.0% during the third quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider’s stock worth $70,000 after buying an additional 1,389 shares during the period. Blue Trust Inc. lifted its stake in shares of Smith & Nephew by 460.5% during the third quarter. Blue Trust Inc. now owns 4,658 shares of the medical equipment provider’s stock worth $145,000 after buying an additional 3,827 shares during the period. Finally, Coerente Capital Management purchased a new stake in shares of Smith & Nephew during the third quarter valued at $202,000. 25.64% of the stock is owned by institutional investors and hedge funds.

Smith & Nephew Trading Down 0.4 %

NYSE SNN opened at $24.44 on Thursday. Smith & Nephew plc has a 1 year low of $23.65 and a 1 year high of $31.72. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.51 and a quick ratio of 1.11. The company has a market capitalization of $10.68 billion, a PE ratio of 12.47, a P/E/G ratio of 1.41 and a beta of 0.84. The company has a fifty day moving average of $26.05 and a 200 day moving average of $27.87.

Wall Street Analyst Weigh In

SNN has been the subject of a number of research analyst reports. StockNews.com lowered Smith & Nephew from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, November 12th. Deutsche Bank Aktiengesellschaft downgraded Smith & Nephew from a “buy” rating to a “hold” rating in a report on Friday, November 1st. Finally, Berenberg Bank lowered Smith & Nephew from a “buy” rating to a “hold” rating in a research report on Wednesday, November 6th.

Smith & Nephew Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.